SEC Form 4 · accession 0001144204-16-117850
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Douglas W Losordo
Officer — See Remarks
Period of report
Aug 5, 2016
Accepted (ET)
Aug 9, 2016 · 8:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 5, 2016 | A | 1,000 | $0.00 | A | 15,399 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares of common stock represent bonus shares that were granted to the Reporting Person pursuant to his employment agreement with the Issuer, dated as of July 23, 2013.
- F2Includes 4,748 shares of unvested restricted stock.
Remarks
Senior Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer. All share numbers and per share prices disclosed in this Form 4 give effect to the Issuer's one-for-ten reverse stock split of its common stock effected on July 28, 2016.